| |
 |
ARTICLES 
|
|
| Why has so much chemotherapy done so little in head and neck cancer? |
| SG Taylor, 4th |
|
JCO Jan 1 1987: 1–3.
[PDF]
|
 |
| Adjuvant chemotherapy of osteosarcoma: no runs, no hits, two men left on base |
| JF Holland |
|
JCO Jan 1 1987: 4–6.
[PDF]
|
|
| ABVD versus MOPP: which is better? |
| SA Rosenberg |
|
JCO Jan 1 1987: 7.
[PDF]
|
|
| Clinical staging in rhabdomyosarcoma: current limitations and future prospects |
| PA Pizzo and TJ Triche |
|
JCO Jan 1 1987: 8–9.
[PDF]
|
|
|
An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck |
| |
TJ Ervin, JR Clark, RR Weichselbaum, BG Fallon, D Miller, RL Fabian, MR Posner, CM Norris, Jr, SA Tuttle, and DA Schoenfeld |
| |
JCO Jan 1 1987: 10–20.
[Abstract]
[PDF]
|
|
|
Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial |
| |
F Eilber, A Giuliano, J Eckardt, K Patterson, S Moseley, and J Goodnight |
| |
JCO Jan 1 1987: 21–26.
[Abstract]
[PDF]
|
|
|
Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy |
| |
A Santoro, G Bonadonna, P Valagussa, R Zucali, S Viviani, F Villani, AM Pagnoni, V Bonfante, R Musumeci, and F Crippa |
| |
JCO Jan 1 1987: 27–37.
[Abstract]
[PDF]
|
|
|
Radiation therapy salvage of Hodgkin's disease following chemotherapy failure |
| |
KA Fox, SM Lippman, JR Cassady, RS Heusinkveld, and TP Miller |
| |
JCO Jan 1 1987: 38–45.
[Abstract]
[PDF]
|
|
|
Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS-II) |
| |
W Lawrence, Jr, EA Gehan, DM Hays, M Beltangady, and HM Maurer |
| |
JCO Jan 1 1987: 46–54.
[Abstract]
[PDF]
|
|
|
Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients |
| |
GM Clark, GW Sledge, Jr, CK Osborne, and WL McGuire |
| |
JCO Jan 1 1987: 55–61.
[Abstract]
[PDF]
|
|
|
Screening for recurrent breast cancer--its effectiveness and prognostic value |
| |
R Tomin and WL Donegan |
| |
JCO Jan 1 1987: 62–67.
[Abstract]
[PDF]
|
|
|
Factors influencing options in primary breast cancer treatment |
| |
WH Wolberg, MA Tanner, EP Romsaas, DL Trump, and JF Malec |
| |
JCO Jan 1 1987: 68–74.
[Abstract]
[PDF]
|
|
|
High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study |
| |
HD Preisler, A Raza, M Barcos, N Azarnia, R Larson, I Walker, M Browman, H Grunwald, P D'Arrigo, and T Doeblin |
| |
JCO Jan 1 1987: 75–82.
[Abstract]
[PDF]
|
|
|
Phase II clinical trial of triazinate in combination with mitomycin C for patients with advanced gastric cancer |
| |
MJ O'Connell, AJ Schutt, CG Moertel, and RG Hahn |
| |
JCO Jan 1 1987: 83–85.
[Abstract]
[PDF]
|
|
|
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study |
| |
MK Samson, LP Wasser, EC Borden, HJ Wanebo, RH Creech, M Phillips, and LH Baker |
| |
JCO Jan 1 1987: 86–91.
[Abstract]
[PDF]
|
|
|
A phase I study of menogaril in patients with advanced cancer |
| |
TD Brown, RC Donehower, LB Grochow, AP Rice, and DS Ettinger |
| |
JCO Jan 1 1987: 92–99.
[Abstract]
[PDF]
|
|
|
Malignant melanoma in the elderly |
| |
HJ Cohen, E Cox, K Manton, and M Woodbury |
| |
JCO Jan 1 1987: 100–106.
[Abstract]
[PDF]
|
|
|
The impact of palliative irradiation on the management of patients with acquired immune deficiency syndrome |
| |
MP Nobler, ME Leddy, and SH Huh |
| |
JCO Jan 1 1987: 107–112.
[Abstract]
[PDF]
|
|
|
A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non- small-cell lung cancer |
| |
WK Evans, DW Nixon, JM Daly, SS Ellenberg, L Gardner, E Wolfe, FA Shepherd, R Feld, R Gralla, and S Fine |
| |
JCO Jan 1 1987: 113–124.
[Abstract]
[PDF]
|
|
|
Superficial bladder cancer: the primacy of grade in the development of invasive disease |
| |
FM Torti, BL Lum, D Aston, N MacKenzie, M Faysel, LD Shortliffe, and F Freiha |
| |
JCO Jan 1 1987: 125–130.
[Abstract]
[PDF]
|
|
|
A new technique for placement of tunneled subclavian right atrial catheters: experience with 130 cases |
| |
M Troxell and R Mansour |
| |
JCO Jan 1 1987: 131–136.
[Abstract]
[PDF]
|
|
|
A totally implanted venous access system used in pediatric patients with cancer |
| |
RJ Shulman, S Rahman, D Mahoney, WJ Pokorny, and R Bloss |
| |
JCO Jan 1 1987: 137–140.
[Abstract]
[PDF]
|
|
|
Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research |
| |
F Roila, M Tonato, C Basurto, M Bella, R Passalacqua, D Morsia, F DiCostanzo, D Donati, E Ballatori, and G Tognoni |
| |
JCO Jan 1 1987: 141–149.
[Abstract]
[PDF]
|
|
| Suppressor cell function in solid tumor cancer patients |
| J Von Roenn, JE Harris, and DP Braun |
|
JCO Jan 1 1987: 150–159.
[PDF]
|
|
| Creatine kinase BB isoenzyme as a marker of CNS metastases in patients with small-cell lung cancer |
| J Matias-Guiu, R Colomer, A Ruibal, I Bonaventura, M Boada, and JM Martinez-Vazquez |
|
JCO Jan 1 1987: 160a–161.
[PDF]
|
|
| Early results of the monoclonal antibody OVTL3 in specific detection of ovarian cancer |
| AA Epenetos, JP Lavender, P Kenemans, and L Poels |
|
JCO Jan 1 1987: 160b.
[PDF]
|
|
| Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer |
| GA Ratkin |
|
JCO Jan 1 1987: 161–162.
[PDF]
|
|
